These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 13248943)

  • 1. Effect of reserpine (serpasil) and hydralazine (apresoline) on experimental steroid hypertension.
    GAUNT R; ANTONCHAK N; MILLER GJ; RENZI AA
    Am J Physiol; 1955 Jul; 182(1):63-8. PubMed ID: 13248943
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of hypertension with reserpine (serpasil) alone and in combination with hydralazine (apresoline).
    STUPPY LJ; TOBER JN
    Angiology; 1955 Jun; 6(3):253-9. PubMed ID: 13275730
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reserpine (serpasil) alone and combined with apresoline, in ambulant therapy of hypertension].
    STURUP H
    Ugeskr Laeger; 1955 May; 117(18):564-8. PubMed ID: 13247434
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacodynamic differentiation of apresoline, serpasil and chlorpromazine by their effect on water retention in the rat].
    MEIER R; BRUNI C; TRIPOD J
    Arch Int Pharmacodyn Ther; 1955 Dec; 104(2):137-45. PubMed ID: 13314688
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of arterial hypertension with the modern hypotensive agents nepresol and serpasil.
    IVANCIC R
    Lijec Vjesn; 1954; 76(9-10):481-7. PubMed ID: 13243796
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug therapy of hypertension. II. Experience with reserpine, apresoline, ansolysen, ecolid, and mecamylamine (inversine).
    MOSER M; MACAULAY AI; GRANZEN R; TROUT KW
    N Y State J Med; 1956 Aug; 56(16):2487-97. PubMed ID: 13348892
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of piezogram in indications and results of the treatment of hypertension with hydralazine and reserpine].
    DONZELOT E; MEYER-HEINE A; METIANU C; KERVOELEN P; SERAFINI V
    Acta Med Scand Suppl; 1956; 312():199-205. PubMed ID: 13339168
    [No Abstract]   [Full Text] [Related]  

  • 8. Reserpine-hydralazine combination therapy of hypertensive disease, with hydralazine in doses generally below the toxic range.
    LEE RE; SELIGMANN AM; GOEBEL D; FULTON LA; CLARK MA
    Ann Intern Med; 1956 Mar; 44(3):456-65. PubMed ID: 13303018
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of arterial hypertension with reserpine and hydrazinophthalazine].
    RIU J
    Sem Med; 1956 Mar; 108(10):331-2. PubMed ID: 13324293
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of reserpine and its combination with hydralazine on blood pressure and renal hemodynamics during the hypertensive phase of acute nephritis in children.
    ETTELDORF JN; SMITH JD; JOHNSON C
    J Pediatr; 1956 Feb; 48(2):129-39. PubMed ID: 13295957
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy in hypertension; clinical experience with serpasil, serpasil-retalin and serpasilnepresol].
    ESSELLIER AF; GOERRE J; WEGMANN A
    Schweiz Med Wochenschr; 1955 Aug; 85(34):808-11. PubMed ID: 13255838
    [No Abstract]   [Full Text] [Related]  

  • 12. [Research on the effects of an active principle of Rauwolfia serpentina (serpasil) on the cephaloretinal circulation in hypertensive patients].
    LEONARDI F
    Boll Ocul; 1955 Dec; 34(12):741-50. PubMed ID: 13304185
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined 1-hydrazinophthalazine and Rauwolfia serpentina in therapy of arterial hypertension].
    FAERCHTEIN I; GINEFRA P
    Med Cir Farm; 1955 May; 229():163-72. PubMed ID: 13244050
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rauwolfia serpentina. I. Comparative studies on the effects of reserpine and serpentine].
    BILECKI G; JUST W; WEIDEL E
    Z Gesamte Inn Med; 1955 Dec; 10(23-24):1097-104. PubMed ID: 13312419
    [No Abstract]   [Full Text] [Related]  

  • 15. Further characterization of central effects of reserpine (serpasil).
    SCHNEIDER JA
    Am J Physiol; 1955 Apr; 181(1):64-8. PubMed ID: 14376571
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy of hypertension with Rauwolfia alkaloids and hydrazinophthalazine preparations].
    TARJAN P; KONIG M
    Orv Hetil; 1956 May; 97(22):595-600. PubMed ID: 13349183
    [No Abstract]   [Full Text] [Related]  

  • 17. [THE GROUP OF ANTIHYPERTENSIVE DRUGS].
    SCHRIEVER K
    Med Monatsschr; 1963 Oct; 17():620-3 CONTD. PubMed ID: 14103621
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological studies on yohimbic acid ethyl ester (A 38) and 4-=2-(p-butoxyphenyl)-1,3-dioxolan-2-ylmethyl=-morpholine methobromide (Q 160) as well as the influence of these substances on reserpine action].
    KLUPP H
    Arzneimittelforschung; 1955 Aug; 5(8):432-6. PubMed ID: 13276244
    [No Abstract]   [Full Text] [Related]  

  • 19. [Topical determination of cerebral impact of reserpine (serpasil)].
    GANGLOFF H; MONNIER M
    Experientia; 1955 Oct; 11(10):404-7. PubMed ID: 13277467
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of serpasil on retinal circulation. VII. Experimental pharmacological studies].
    ZAHN K
    Cesk Oftalmol; 1956 Jun; 12(3):174-7. PubMed ID: 13343323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.